The 5th Gene Therapy Analytical Development Europe – What to Expect in 2024?

In the face of evolving regulatory guidelines and mounting scrutiny, the 5th Gene Therapy Analytical Development Europe Summit will discuss ways you can apply contemporary analytical tools to guarantee the consistency, quality, and safety of your gene therapy products.

Join leading CMC, regulatory, QC, analytical and process development experts to gain access to novel data and recent case studies by industry professionals from AstraZeneca, the MHRA, Novartis, Sarepta Therapeutics, Roche, Sanofi, and many more.

Enjoy in-depth, valuable networking opportunities with scientists and senior decision makers from small biotech through to large pharma – perfect for those looking to further industry relationships.

To know more visit: https://ter.li/vz0jr4